Insider · CIK 0001197032
Ian F Smith
director
Files at SLDB (Solid Biosciences Inc.), FHTX (Foghorn Therapeutics Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | SLDB Solid Biosciences Inc. | MOption exercise Common Stock | +3,440 | - | - | 141,585 | 6 d ago |
| Oct 2, 2026 | SLDB Solid Biosciences Inc. | MOption exercise Restricted Stock Unitsderivative | -3,440 | $0.00 | $0 | 3,440 | 6 d ago |
| Jun 17, 2025 | FHTX Foghorn Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $4.79 | $120k | 25,000 | Jun 17, 2025 |
| Jun 12, 2025 | SLDB Solid Biosciences Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +77,500 | $0.00 | $0 | 77,500 | Jun 13, 2025 |
| Apr 6, 2025 | SLDB Solid Biosciences Inc. | MOption exercise Common Stock | +4,574 | - | - | 117,546 | Apr 8, 2025 |
| Apr 6, 2025 | SLDB Solid Biosciences Inc. | MOption exercise Restricted Stock Unitsderivative | -4,574 | $0.00 | $0 | 13,719 | Apr 8, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.